{"id":82647,"date":"2026-04-03T20:03:18","date_gmt":"2026-04-03T20:03:18","guid":{"rendered":"https:\/\/www.europesays.com\/at\/82647\/"},"modified":"2026-04-03T20:03:18","modified_gmt":"2026-04-03T20:03:18","slug":"bayer-aktie-vertagt-entscheidung-koennte-aber-bald-durchstarten-boersennews-de","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/at\/82647\/","title":{"rendered":"Bayer &#8211; Aktie vertagt Entscheidung; k\u00f6nnte aber bald durchstarten &#8211; B\u00f6rsenNEWS.de"},"content":{"rendered":"<p><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMijgJBVV95cUxPd3pXb2p1MmQwQXQyQm9vdjUzQzlIYS05bEJ0cXZrQ2l1cXR6TFlQUm5GQ1BXSkhKUlRxdXA5RnJ2d1pCZDJGaDloN0ZYQUZRaXdaS0piRFJnSFhDeXJwQUowdkJRQl9jUTZCWlVzRG1RbTAzcjhMN2Q4bTZ4U0xNb2lINHJQMHhCNDNqbzhlS1laWUNYa3dNaEpKN3VSQkZIcWJuV2h0UVQxempqNVlESFRlaU9wTGRKUlh5TjJERzJvcDRLOHFYZDZpZGM5Mm5DOEFBcVRZNXR1YjIyMnNPeDhNUDRDUDNxRTM0ZkFYMTdQcHdCVWV2RHBQTklfc3VBYVlUYTZ0R1JoMDNLQ1E?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Bayer &#8211; Aktie vertagt Entscheidung; k\u00f6nnte aber bald durchstarten<\/a>&nbsp;&nbsp;B\u00f6rsenNEWS.de<a href=\"https:\/\/news.google.com\/rss\/articles\/CBMiZEFVX3lxTE9PTFVMbGJPNGxMcWNodmxHOG14R3VzQzBXckdtS1hCeF9fcDNEaExQckVURkZoWDVqLTMtdGx6X0ZwZmgwcFhKdW50MFZCOEc1Zk5xT1RraThVd29xR2U4WVhzeFE?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">BAYER &#8211; Um Haaresbreite!<\/a>&nbsp;&nbsp;stock3<a href=\"https:\/\/news.google.com\/rss\/articles\/CBMikgFBVV95cUxNMmFlVkYxLVNBUGlWaVo4a1lZRGRudTlKN0pHd0ZEa0NfTGdveTQtRXUwNVg4VVYxQWdBNVdkZGc0cDVNZTZZbERhUWk3VGRZWHZXNjkwRGpmRlJEYzA4dVRZM2c3WnBhSWNoczQ1NUY4QXhSQS1hQU1nbWZKMHRRLUZ2Y29ITndLRU9KWkU2UTlkUQ?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Finerenon bei Herzinsuffizienz mit LVEF \u2265 40% zugelassen<\/a>&nbsp;&nbsp;journalmed<a href=\"https:\/\/news.google.com\/rss\/articles\/CBMi-wFBVV95cUxNODBfeHdCRnpKcnE0VTZrVlIwTWR0NGlmdlcyTUhyTkhZOGZJSmFMNjdhdnN5Mm5tOU5DbEYyNFk5U3gteUJPZHlaSXRmQklXMlBaelVmYW1rQXpkYWdUeDFFb0ZITXZnekNLcmxEcl9PMzlFX2NnVjJNb21mbi1zMjVQNEVXWV9wSU5aVDVNdnUtY1hVajZxRTkweV9kd216WmtFVnB4amFlaXZCNlFBZUE1WldMaTJWOS1rcXA1cHdaa0JiYnF5Q3F6NDMyWlZiS3BEeEhZQll6RlRISkdvN1VZQjhzNTMxNlQxX3dra1NGZE1oeEpJZ042RQ?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Bayer treibt zuk\u00fcnftiges Wachstum mit leistungsst\u00e4rkstem Pharma-Portfolio aller Zeiten und vielversprechender Entwicklungspipeline voran<\/a>&nbsp;&nbsp;Bayer<a href=\"https:\/\/news.google.com\/rss\/articles\/CBMimwFBVV95cUxQUVJoVVh1NnV3eDFhV1k4aUVidFpJdjgtSW50X0xsamtsU1VpWlNYSFBxUmp6NEExRGNSS1EwVW91ZmJ4U0EyaGVCaktWdXU1VXR1RFNRWlRJMWh3RGpweDdxencxU0dhdUN6Z2JRT2l6d0lWMHVBTzl3T0s1d3diaXV3UDdLSjU0aVZzRlNTR1FZYk5XQXNPUVIzUQ?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Bayer Aktie: Zulassung und Margenziel<\/a>&nbsp;&nbsp;AD HOC NEWS<\/p>\n","protected":false},"excerpt":{"rendered":"Bayer &#8211; Aktie vertagt Entscheidung; k\u00f6nnte aber bald durchstarten&nbsp;&nbsp;B\u00f6rsenNEWS.deBAYER &#8211; Um Haaresbreite!&nbsp;&nbsp;stock3Finerenon bei Herzinsuffizienz mit LVEF \u2265 40%&hellip;\n","protected":false},"author":2,"featured_media":82648,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[15058,46,42,3000,95,31439,90,89,9677,91,94,44,576,93,92],"class_list":{"0":"post-82647","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-unternehmen-maerkte","8":"tag-aktienmaerkte","9":"tag-at","10":"tag-austria","11":"tag-bayer","12":"tag-business","13":"tag-comeback-qualitaeten","14":"tag-companies","15":"tag-companies-markets","16":"tag-dax","17":"tag-markets","18":"tag-maerkte","19":"tag-oesterreich","20":"tag-trump","21":"tag-unternehmen","22":"tag-unternehmen-maerkte"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@at\/116342568035475616","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/posts\/82647","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/comments?post=82647"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/posts\/82647\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/media\/82648"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/media?parent=82647"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/categories?post=82647"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/tags?post=82647"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}